Finance

Lists
Why is 000930 down 3.53%?
Dive Deeper
000930:SHE
Cofco Biotechnology Co Ltd
CN¥5.19
-3.53%
(-0.19) 1D
Oct 12, 3:04:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000930...
Open
CN¥5.38
High
CN¥5.49
Low
CN¥5.17
Mkt. cap
9.99B
Avg. vol.
68.32M
Volume
51.20M
Dividend
0.58%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jul 16, 2026
52-wk high
CN¥8.14
52-wk low
CN¥4.24
EPS
-CN¥0.13
Shares outstanding
1.86B
No. of employees
5K
Open
CN¥5.38
High
CN¥5.49
Low
CN¥5.17
Mkt. cap
9.99B
Avg. vol.
68.32M
Volume
51.20M
Dividend
0.58%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jul 16, 2026
52-wk high
CN¥8.14
52-wk low
CN¥4.24
EPS
-CN¥0.13
Shares outstanding
1.86B
No. of employees
5K
News stories
From web sources and news partners
About Cofco Biotechnology Co Ltd
CEO-
Employees4.57K
FoundedAug 28, 1998
Headquarters-
SectorSpeciality chemicals
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
4.45B
4.25B
3.88B
4.32B
Cost of goods sold
3.99B
4.35B
3.66B
4.25B
Cost of revenue
3.99B
4.35B
3.66B
4.25B
Research and development expenses
32.18M
27.06M
17.42M
16.24M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
178.61M
210.53M
179.85M
155.70M
Operating expense
234.88M
261.71M
217.14M
192.10M
Total operating expenses
4.22B
4.61B
3.87B
4.44B
Operating income
225.46M
-363.64M
4.39M
-129.75M
Other non operating income
19.32M
-7.80M
6.21M
-3.87M
EBT including unusual items
-13.48M
-60.54M
-118.54M
-50.59M
EBT excluding unusual items
249.83M
-408.45M
-6.90M
-140.86M
Income tax expense
13.75M
-23.77M
5.49M
1.36M
Effective tax rate
-101.96%
39.27%
-4.63%
-2.69%
Other operating expenses
25.55M
21.99M
18.34M
21.30M
Net income
-28.06M
-40.82M
-121.44M
-47.85M
Net profit margin
-0.63%
-0.96%
-3.13%
-1.11%
Earnings per share
-
-
-
-
Interest and investment income
5.37M
9.99M
1.87M
3.01M
Interest expense
-24.30M
-11.05M
-19.38M
-21.03M
Net interest expenses
-18.93M
-1.06M
-17.51M
-18.01M
Depreciation and amortization charges
-
-
-
-
EBITDA
345.84M
-240.39M
127.64M
-4.36M
Gain or loss from assets sale
452.04K
-60.10M
-
-449.53K
AI content may include mistakes. Learn more
Google apps